» Authors » Birgitte Sloth

Birgitte Sloth

Explore the profile of Birgitte Sloth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 437
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sivakumar K, Cochrane T, Sloth B, Ashar H, Laurent D, Tanko L, et al.
Neurology . 2020 Jul; 95(14):e1971-e1978. PMID: 32690797
Objective: To assess the long-term safety and tolerability and to monitor benefits of extended use of bimagrumab in individuals with sporadic inclusion body myositis (sIBM) who completed a single-dose core...
2.
Rao V, Webster S, Dalm V, Sediva A, van Hagen P, Holland S, et al.
Blood . 2017 Oct; 130(21):2307-2316. PMID: 28972011
Pathogenic gain-of-function variants in the genes encoding phosphoinositide 3-kinase δ (PI3Kδ) lead to accumulation of transitional B cells and senescent T cells, lymphadenopathy, and immune deficiency (activated PI3Kδ syndrome [APDS])....
3.
Krog-Mikkelsen I, Sloth B, Dimitrov D, Tetens I, Bjorck I, Flint A, et al.
J Nutr . 2011 Jul; 141(9):1679-84. PMID: 21775528
At present, it is difficult to determine whether glycemic index (GI) is an important tool in the prevention of lifestyle diseases, and long-term studies investigating GI with diets matched in...
4.
Sloth B, Due A, Larsen T, Holst J, Heding A, Astrup A
Br J Nutr . 2008 Dec; 101(12):1846-58. PMID: 19079942
We aimed to test the effects of three different weight maintenance diets on appetite, glucose and fat metabolism following an initial low-energy diet (LED) induced body weight loss. Following an...
5.
Wolever T, Brand-Miller J, Abernethy J, Astrup A, Atkinson F, Axelsen M, et al.
Am J Clin Nutr . 2008 Jan; 87(1):247S-257S. PMID: 18175765
Background: Many laboratories offer glycemic index (GI) services. Objective: We assessed the performance of the method used to measure GI. Design: The GI of cheese-puffs and fruit-leather (centrally provided) was...
6.
Jensen L, Sloth B, Krog-Mikkelsen I, Flint A, Raben A, Tholstrup T, et al.
Am J Clin Nutr . 2008 Jan; 87(1):97-105. PMID: 18175742
Background: The development of obesity has been suggested to involve plasminogen activator inhibitor-1 (PAI-1) and tissue inhibitor of proteinases-1 (TIMP-1). Plasma PAI-1 is elevated in obesity. A low-glycemic-index (LGI) diet...
7.
Sloth B, Davidsen L, Holst J, Flint A, Astrup A
Am J Physiol Endocrinol Metab . 2007 Jun; 293(2):E604-9. PMID: 17566112
Intraveneous (i.v.) PYY(3-36) infusions have been reported to reduce energy intake (EI) in humans, whereas few studies exist on effects of PYY(1-36). The aim of the present study was to...
8.
Flint A, Moller B, Raben A, Sloth B, Pedersen D, Tetens I, et al.
Am J Clin Nutr . 2006 Dec; 84(6):1365-73. PMID: 17158418
Background: The importance of the postprandial glycemic and insulinemic responses for appetite and energy intake (EI) is controversial. Objective: The aim of the study was to test the hypothesis that...
9.
Sloth B, Holst J, Flint A, Gregersen N, Astrup A
Am J Physiol Endocrinol Metab . 2006 Dec; 292(4):E1062-8. PMID: 17148749
Peptide YY (PYY)(3-36) has been shown to produce dramatic reductions in energy intake (EI), but no human data exist regarding energy expenditure (EE), glucose and fat metabolism. Nothing is known...
10.
Sloth B, Krog-Mikkelsen I, Flint A, Tetens I, Bjorck I, Vinoy S, et al.
Am J Clin Nutr . 2004 Jul; 80(2):337-47. PMID: 15277154
Background: The role of glycemic index (GI) in appetite and body-weight regulation is still not clear. Objective: The objective of the study was to investigate the long-term effects of a...